Bipolar I disorder clinical trials
26 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
- Healthy Lifestyles for Bipolar Disorder
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
- An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
- Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
- A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- CLOZAPINE Response in Biotype-1
- Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
- Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
- FOCUS Bipolar: Families Opening Conversations for Understanding Signs
- Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Cerebellar Modulation of Cognition in Psychosis
- The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
- Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
- Open Label Extension Study of NCT06221852
- Psychiatric Genotype/Phenotype Project Repository
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Bipolar I disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.